Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Cancer is a leading cause of global mortality.
• Conventional anticancer drugs often lack tumor selectivity, leading to systemic toxicity.
• Nanodrugs offer potential advantages in cancer therapy due to their unique pharmacokinetic properties.

Purpose of the Study:

• To review the progress and prospects of tumor-targeting strategies in cancer therapy.
• To detail the application of the enhanced permeability and retention (EPR) effect for nanodrug delivery.
• To discuss the benefits of nanodrugs in overcoming limitations of traditional anticancer agents.

Main Methods:

• Review of existing literature on nanodrugs and the EPR effect in cancer therapy.
• Analysis of nanodrug behavior after intravenous administration, including renal clearance and plasma levels.
• Examination of tumor accumulation mechanisms, particularly the EPR effect and lymphatic drainage.

Main Results:

• Nanodrugs administered intravenously exhibit prolonged circulation and reduced renal clearance.
• The EPR effect facilitates significant nanodrug accumulation within tumors.
• Tumor lymphatic drainage is limited, contributing to sustained high concentrations of nanodrugs in the tumor microenvironment.

Conclusions:

• The EPR effect is a key mechanism for passive tumor targeting with nanodrugs.
• Nanodrugs demonstrate potential for enhanced tumor selectivity and therapeutic efficacy.
• Further research into EPR-mediated nanodrug delivery holds promise for advancing cancer therapy.